跳至主要内容
临床试验/EUCTR2012-005291-34-NL
EUCTR2012-005291-34-NL进行中(未招募)1 期

Perioperative intravenous insulin, GIK or GLP-1 treatment in DM - PILGRIM

AMC, Amsterdam0 个研究点开始时间: 2013年8月13日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Signed informed consent
  • known diabetes mellitus type II for > 3 months
  • aged 18-85 years
  • scheduled for elective non-cardiac surgery
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 215
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 100

排除标准

  • Oral corticosteroid use
  • - use > 1 IU/kg insulin for diabetes treatment
  • Planned for day-care (ambulant) surgery
  • Planned ICU stay post-operatively
  • History of chronic pancreatitis or idiopathic acute pancreatitis
  • Impaired renal function defined as serum-creatinine = 133 µmol/L for males and = 115 µmol/L for females
  • Females of child bearing potential who are pregnant, breast-feeding or intend to become pregnant or are not using adequate contraceptive methods (adequate contraceptive measures as required by local law or practice)
  • Known or suspected allergy to trial product(s) or related products
  • Any condition that the local investigator feels would interfere with trial participation or the evaluation of results

研究者

发起方
AMC, Amsterdam

相似试验

Perioperative intravenous insulin, GIK or GLP-1... | 临床试验